Suppr超能文献

健美运动员的身体成分与人体测量学:癸酸诺龙给药后的局部变化

Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration.

作者信息

Hartgens F, Van Marken Lichtenbelt W D, Ebbing S, Vollaard N, Rietjens G, Kuipers H

机构信息

Netherlands Centre for Doping Affairs, Capelle aan den Ijssel.

出版信息

Int J Sports Med. 2001 Apr;22(3):235-41. doi: 10.1055/s-2001-18679.

Abstract

The purpose of the present study was to investigate regional changes in body composition and anthropometric variables induced by nandrolone decanoate in bodybuilders. In a randomized, double blind, placebo controlled design 16 subjects received weekly intramuscular injections containing 200 mg nandrolone decanoate (ND) or placebo. Composition of total body and body parts were assessed using dual energy X-ray absorptiometry (DEXA), skinfolds and circumferences. Measurements were performed at baseline, after 8 weeks ND administration period and 6 weeks after drug withdrawal. DEXA revealed that total body mass (from 76.16 +/- 2.70 to 78.73 +/- 4.07 kg, p<0.5) and bone-free lean mass (from 59.54 +/- 2.36 to 63.06 +/- 2.99 kg, p < 0.025) increased significantly during ND administration whereas bone mineral mass remained unchanged. Six weeks after drug cessation bone-free lean mass was still increased compared to baseline levels. During ND administration significant increments of bone-free lean mass of the trunk (+ 2.03 kg) and legs (+ 1.08 kg) could be observed. Percentage fat of the legs decreased during the drug intervention period (-1.9%) and remained lowered six weeks after drug withdrawal. No alteration in any variable of the arms was observed. Skinfolds did not change during the entire study period in both groups. After 8 weeks ND administration circumference of the neck was increased (+0.9 cm) significantly although all circumferences underwent non-significant gains. In conclusion, the intramuscular administration of nandrolone decanoate (200 mg per week) during eight weeks induced an increase of body weight and bone-free lean body mass in bodybuilders that was mainly situated in the trunk and legs as determined by DEXA. The changes in the trunk were reflected in the circumferences but not the alterations in the legs. Skinfolds were not able to detect changes of fat mass of body parts. DEXA revealed that total fat mass and total percentage fat remained unaffected by drug administration while percentage fat of the legs decreased and remained lowered after drug cessation. These data indicate that changes of the composition of body parts induced by ND are elucidated less accurately by circumferences or skinfolds rather than by DEXA.

摘要

本研究的目的是调查癸酸诺龙对健美运动员身体成分和人体测量学变量的区域变化。在一项随机、双盲、安慰剂对照设计中,16名受试者每周接受一次肌肉注射,注射物为含200毫克癸酸诺龙(ND)或安慰剂。使用双能X线吸收法(DEXA)、皮褶厚度和周长评估全身及身体各部位的成分。在基线期、ND给药8周后以及停药6周后进行测量。DEXA显示,在ND给药期间,总体重(从76.16±2.70千克增至78.73±4.07千克,p<0.5)和去脂瘦体重(从59.54±2.36千克增至63.06±2.99千克,p<0.025)显著增加,而骨矿物质质量保持不变。停药6周后,去脂瘦体重仍高于基线水平。在ND给药期间,可观察到躯干(增加2.03千克)和腿部(增加1.08千克)的去脂瘦体重显著增加。在药物干预期间,腿部脂肪百分比下降(-1.9%),停药6周后仍保持较低水平。未观察到手臂任何变量的改变。两组的皮褶厚度在整个研究期间均未改变。ND给药8周后,颈部周长显著增加(+0.9厘米),尽管所有周长均有非显著性增加。总之,在八周内每周肌肉注射癸酸诺龙(200毫克)会使健美运动员的体重和去脂瘦体重增加,主要位于躯干和腿部,这是由DEXA测定的。躯干的变化反映在周长上,但腿部的变化并非如此。皮褶厚度无法检测身体各部位脂肪量的变化。DEXA显示,总体脂肪量和总脂肪百分比不受药物给药影响,而腿部脂肪百分比下降,停药后仍保持较低水平。这些数据表明,与DEXA相比,周长或皮褶厚度对ND引起的身体各部位成分变化的阐释不够准确。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验